Covered recipient · General Payments record
LESLIE C VERUCCI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2023
$2,254.47
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,119.14 | 13 |
| Education | $246.04 | 3 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $253.39 | 3 |
| Lilly USA, LLC | $210.16 | 3 |
| Acerta Pharma LLC | $199.49 | 2 |
| ImmunoGen, Inc. | $120.00 | 1 |
| Gilead Sciences, Inc. | $100.00 | 1 |
| SEAGEN INC. | $99.99 | 1 |
| Karyopharm Therapeutics Inc. | $84.21 | 1 |
| E.R. Squibb & Sons, L.L.C. | $82.31 | 1 |
| G1 Therapeutics, Inc. | $80.33 | 1 |
| GlaxoSmithKline, LLC. | $71.04 | 1 |
| QIAGEN, LLC | $64.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $124.99 | 07/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011251245 | CMS |
| AstraZeneca Pharmaceuticals LP | $74.50 | 08/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014956757 | CMS |
| E.R. Squibb & Sons, L.L.C. | $82.31 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015499261 | CMS |
| G1 Therapeutics, Inc. | $80.33 | 08/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059921589 | CMS |
| Gilead Sciences, Inc. | $100.00 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025523423 | CMS |
| GlaxoSmithKline, LLC. | $71.04 | 11/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004192153 | CMS |
| ImmunoGen, Inc. | $120.00 | 12/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1017255903 | CMS |
| Janssen Biotech, Inc. | $74.40 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988073583 | CMS |
| Janssen Biotech, Inc. | $79.04 | 07/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988073573 | CMS |
| Janssen Biotech, Inc. | $99.95 | 07/11/2023 | Education | Undisputed | 01/23/2026 | 988073563 | CMS |
| Karyopharm Therapeutics Inc. | $84.21 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056916889 | CMS |
| Lilly USA, LLC | $103.60 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033176109 | CMS |
| Lilly USA, LLC | $46.10 | 04/05/2023 | Education | Undisputed | 01/23/2026 | 1033019061 | CMS |
| Lilly USA, LLC | $60.46 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033145129 | CMS |
| QIAGEN, LLC | $64.26 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060257619 | CMS |
| Seagen Inc. | $99.99 | 08/03/2023 | Education | Undisputed | 01/23/2026 | 995772647 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.